Leserbrief
Doxycycline and Schizophrenia: Response to Letters
American Journal of Psychiatry · 01.08.2026 · 183 (8) · 595-596
DOI: 10.1176/appi.ajp.20260263 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Psychiatry, erschienen am 01.08.2026. Verfasst von Ian Kelleher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Child/Adolescent PsychiatrySchizophrenia Spectrum and Other Psychotic Disorders
Autor:innen und Institutionen
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh.
- Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
- School of Medicine, University College Dublin, Dublin.
- Saint John of God Hospitaller Services Group, Dublin.
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki.
Zitieren
APA
Kelleher, I., Lång, U., Metsälä, J., & Healy, C. (2026). Doxycycline and Schizophrenia: Response to Letters. American Journal of Psychiatry, 183(8), 595-596. https://doi.org/10.1176/appi.ajp.20260263
Vancouver
Kelleher I, Lång U, Metsälä J, Healy C. Doxycycline and Schizophrenia: Response to Letters. American Journal of Psychiatry. 2026;183(8):595-596. doi:10.1176/appi.ajp.20260263
BibTeX
@article{Kelleher2026,
author = {Kelleher, Ian and Lång, Ulla and Metsälä, Johanna and Healy, Colm},
title = {Doxycycline and Schizophrenia: Response to Letters},
journal = {American Journal of Psychiatry},
year = {2026},
volume = {183},
number = {8},
pages = {595--596},
doi = {10.1176/appi.ajp.20260263}
}
EUVIMED